2021年7月9日
Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series
SAGE Open Medical Case Reports
- ,
- ,
- ,
- 巻
- 9
- 号
- 開始ページ
- 1
- 終了ページ
- 5
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1177/2050313X2110313
- 出版者・発行元
- SAGE Publications
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history of interstitial pneumonia. We report on 10 non-small cell lung cancer patients with a history of interstitial pneumonia who experienced immune checkpoint inhibitor-induced interstitial pneumonia. The immune checkpoint inhibitor-induced interstitial pneumonia lasted for a median duration of 41.5 days (range = 22–127 days). Eight of the ten patients responded to corticosteroid monotherapy; one patient responded to corticosteroids and the immunosuppressant, tacrolimus; and one patient did not improve after corticosteroid treatment. In non-small cell lung cancer patients with a history of interstitial pneumonia, immune checkpoint inhibitor-induced interstitial pneumonia was generally responds to corticosteroids.
- リンク情報
-
- DOI
- https://doi.org/10.1177/2050313X2110313
- PubMed
- https://www.ncbi.nlm.nih.gov/pubmed/34290871
- PubMed Central
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274086
- URL
- http://journals.sagepub.com/doi/pdf/10.1177/2050313X211031313 本文へのリンクあり
- URL
- http://journals.sagepub.com/doi/full-xml/10.1177/2050313X211031313 本文へのリンクあり
- ID情報
-
- DOI : 10.1177/2050313X2110313
- ISSN : 2050-313X
- eISSN : 2050-313X
- PubMed ID : 34290871
- PubMed Central 記事ID : PMC8274086